Friday, July 1, 2016

BRIEF-Spark says announces publication of positive follow-up data from phase 1 trial of voretigene neparvovec in The Lancet

* Says has initiated a rolling submission of bla with fda on

voretigene neparvovec

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)